Five years ago, there was a Saxenda craze in Korea. People rushed to the clinics because they could easily lose weight with self-injection once a day at home, and there were no central nervous system side effects, unlike existing obesity drugs, which are psychotropic drugs. The saying, 'There is no one in Gangnam who does not take Saxenda' was circulating like a trend. Health authorities also launched an intensive crackdown on the indiscriminate use of Saxenda, but the effectiveness was temporary. Saxenda posted record sales of 42.6 billion won in the second year of domestic launch.

As of 2023, the diet pill craze is showing signs of spreading once again. This is when the next-generation version of Sax